This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y.-L.
Right arrow Articles by Reynolds, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.-L.
Right arrow Articles by Reynolds, T. B.

 Previous Article  |  Next Article 

Infection and Immunity, June 2008, p. 2793-2801, Vol. 76, No. 6
0019-9567/08/$08.00+0     doi:10.1128/IAI.01514-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Candida albicans Uses Multiple Mechanisms To Acquire the Essential Metabolite Inositol during Infection{triangledown}

Ying-Lien Chen, Sarah Kauffman, and Todd B. Reynolds*

Department of Microbiology, University of Tennessee, Knoxville, Tennessee 37996

Received 14 November 2007/ Returned for modification 19 December 2007/ Accepted 28 January 2008

Candida albicans is an important cause of life-threatening systemic bloodstream infections in immunocompromised patients. In order to cause infections, C. albicans must be able to synthesize the essential metabolite inositol or acquire it from the host. Based on the similarity of C. albicans to Saccharomyces cerevisiae, it was predicted that C. albicans may generate inositol de novo, import it from the environment, or both. The C. albicans inositol synthesis gene INO1 (orf19.7585) and inositol transporter gene ITR1 (orf19.3526) were each disrupted. The ino1{Delta}/ino1{Delta} mutant was an inositol auxotroph, and the itr1{Delta}/itr1{Delta} mutant was unable to import inositol from the medium. Each of these mutants was fully virulent in a mouse model of systemic infection. It was not possible to generate an ino1{Delta}/ino1{Delta} itr1{Delta}/itr1{Delta} double mutant, suggesting that in the absence of these two genes, C. albicans could not acquire inositol and was nonviable. A conditional double mutant was created by replacing the remaining wild-type allele of ITR1 in an ino1{Delta}/ino1{Delta} itr1{Delta}/ITR1 strain with a conditionally expressed allele of ITR1 driven by the repressible MET3 promoter. The resulting ino1{Delta}/ino1{Delta} itr1{Delta}/PMET3::ITR1 strain was found to be nonviable in medium containing methionine and cysteine (which represses the PMET3 promoter), and it was avirulent in the mouse model of systemic candidiasis. These results suggest a model in which C. albicans has two equally effective mechanisms for obtaining inositol while in the host. It can either generate inositol de novo through Ino1p, or it can import it from the host through Itr1p.

* Corresponding author. Mailing address: Department of Microbiology, University of Tennessee, F321 Walters Life Sciences Building, Knoxville, TN 37996. Phone: (865) 974-4025. Fax: (865) 974-4007. E-mail: treynol6{at}utk.edu

{triangledown} Published ahead of print on 11 February 2008.

Editor: A. Casadevall

Infection and Immunity, June 2008, p. 2793-2801, Vol. 76, No. 6
0019-9567/08/$08.00+0     doi:10.1128/IAI.01514-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Reynolds, T. B. (2009). Strategies for acquiring the phospholipid metabolite inositol in pathogenic bacteria, fungi and protozoa: making it and taking it. Microbiology 155: 1386-1396 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»